KATIE CARTER: Open Payments
NPI 1700256351 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 44 payments from 15 companies in 2025. Trend: 2023 $1,115 · 2024 $745 · 2025 $934
Food & beverage: $865Education: $69
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $168 |
| Astellas Pharma US Inc | 4 | $124 |
| Radius Health, Inc. | 5 | $113 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $102 |
| Lilly USA, LLC | 1 | $77 |
| Amgen Inc. | 1 | $68 |
| MILLICENT US INC | 3 | $64 |
| Dexcom, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: GEMTESA, Tymlos, ZEPBOUND, EVENITY, Veozah, Dexcom G6 Transmitter, MYFEMBREE, FEMLYV.
Industry payments across AL — which companies pay providers there.
